Alkyl Amines Chemicals announced the approval of the unaudited financial results for the quarter and half-year ended September 30, 2025. Additionally, the board approved a revision in remuneration for Mr. Rakesh S. Goyal, Whole-time Director Operations, effective January 1, 2026, subject to shareholder approval. The Board Meeting convened at 11:45 A.M. and concluded at 1:10 P.M.
Q2 2026 Financial Performance
Alkyl Amines Chemicals has released its unaudited financial results for the quarter and half-year ended September 30, 2025 (Q2 2026). Key highlights from the statement include:
Revenue from Operations: ₹389.41 Crores for the quarter, compared to ₹414.89 Crores in Q2 2025.
Total Revenue: ₹396.83 Crores for the quarter.
Profit before Exceptional Items and Tax: ₹59.11 Crores.
Profit for the period after Tax: ₹42.94 Crores.
Earnings Per Equity Share: Basic ₹8.40 and Diluted ₹8.38 (not annualized).
Remuneration Revision
The Board has approved a revision in the remuneration payable to Mr. Rakesh S. Goyal (Whole-time Director Operations), effective January 1, 2026, until the end of his tenure on May 31, 2027. This is subject to the approval of shareholders via postal ballot.
Assets and Liabilities Highlights
Key figures from the statement of assets and liabilities as of September 30, 2025:
Total Assets: ₹1,766.99 Crores.
Equity Share Capital: ₹10.24 Crores.
Other Equity: ₹1,432.92 Crores.
Cash Flow Summary
Highlights from the cash flow statement for the period ended September 30, 2025:
Net Cash Flow from Operating Activities: ₹75.48 Crores.
Net Cash generated from/ (used in) Investing Activities: ₹(44.23) Crores.
Net Cash generated from/ (used in) Financing Activities: ₹(55.18) Crores.
Source: BSE
